[PDF][PDF] Regulation of class I MHC gene expression in the developing and mature CNS by neural activity

RA Corriveau, GS Huh, CJ Shatz - Neuron, 1998 - cell.com
To elucidate molecular mechanisms underlying activity-dependent synaptic remodeling in
the developing mammalian visual system, we screened for genes whose expression in the …

Vascular contributions to cognitive impairment and dementia including Alzheimer's disease

HM Snyder, RA Corriveau, S Craft, JE Faber… - Alzheimer's & …, 2015 - Elsevier
Scientific evidence continues to demonstrate the linkage of vascular contributions to
cognitive impairment and dementia such as Alzheimer's disease. In December, 2013, the …

Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses

…, G Mckenzie, M Craigon, R Corriveau… - Nature …, 2008 - nature.com
Intrinsic antioxidant defenses are important for neuronal longevity. We found that in rat
neurons, synaptic activity, acting via NMDA receptor (NMDAR) signaling, boosted antioxidant …

[HTML][HTML] White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities

…, AM Brickman, BL Callahan, RA Corriveau… - Alzheimer's & Dementia …, 2019 - Elsevier
White matter hyperintensities (WMHs) are frequently seen on brain magnetic resonance
imaging scans of older people. Usually interpreted clinically as a surrogate for cerebral small …

Vascular contributions to cognitive impairment and dementia (VCID): a report from the 2018 National Heart, Lung, and Blood Institute and National Institute of …

…, L Stoeckel, JI Koenig, RA Corriveau… - Alzheimer's & …, 2020 - Wiley Online Library
Vascular contributions to cognitive impairment and dementia (VCID) are characterized by
the aging neurovascular unit being confronted with and failing to cope with biological insults …

The science of vascular contributions to cognitive impairment and dementia (VCID): a framework for advancing research priorities in the cerebrovascular biology of …

RA Corriveau, F Bosetti, M Emr, JT Gladman… - Cellular and molecular …, 2016 - Springer
The World Health Organization reports that 47.5 million people are affected by dementia
worldwide. With aging populations and 7.7 million new cases each year, the burden of illness …

Alzheimer's disease–related dementias summit 2016: National research priorities

RA Corriveau, WJ Koroshetz, JT Gladman, S Jeon… - Neurology, 2017 - AAN Enterprises
Goal 1 of the National Plan to Address Alzheimer’s Disease is to prevent and effectively treat
Alzheimer disease and Alzheimer disease–related dementias by 2025. To help inform the …

Translational stroke research: vision and opportunities

…, S Cho, MJ Cipolla, D Corbett, RA Corriveau… - Stroke, 2017 - Am Heart Assoc
Bosetti et al NINDS Workshop Recommendations 2633 academia, industry, the Food and
Drug Administration, and other public and private funding agencies. In the context of this …

Recommendations of the Alzheimer's disease–related dementias conference

…, CL Torborg, SP Waddy, BV Zlokovic, RA Corriveau… - Neurology, 2014 - AAN Enterprises
The National Alzheimer's Project Act, signed into law in 2011, mandates a National Plan to
Address Alzheimer's Disease that is updated annually. In the Plan, the term Alzheimer …

Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke

…, Z Deng, T Barr, K Gwinn, R Corriveau… - Neurology, 2016 - AAN Enterprises
Objective: For 3,670 stroke patients from the United Kingdom, United States, Australia,
Belgium, and Italy, we performed a genome-wide meta-analysis of white matter hyperintensity …